Jupiter Asset Management’s Usana Health Sciences USNA Stock Holding History

Jupiter Asset Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,244	Closed	-$978K	–	536
2023 Q4	$978K	Hold	18,244	–	–	0.01%	382
2023 Q3	$1.07M	Hold	18,244	–	–	0.01%	393
2023 Q2	$1.15M	Hold	18,244	–	–	0.01%	419
2023 Q1	$1.15M	Buy	18,244 +5,935	+48%	+$354K	0.02%	330
2022 Q4	$655K	Sell	12,309 -11,513	-48%	-$624K	0.01%	396
2022 Q3	$1.33M	Sell	23,822 -9,230	-28%	-$610K	0.02%	377
2022 Q2	$2.39M	Sell	33,052 -8,571	-21%	-$638K	0.03%	354
2022 Q1	$3.3M	Buy	41,623 +14,237	+52%	+$1.28M	0.04%	306
2021 Q4	$2.77M	Buy	+27,386	New	+$2.73M	0.03%	314
2021 Q1	–	Sell	-7,259	Closed	-$560K	–	665
2020 Q4	$560K	Sell	7,259 -23,382	-76%	-$1.81M	0.01%	502
2020 Q3	$2.26M	Buy	+30,641	New	+$2.46M	0.02%	401

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jupiter Asset Management's USNA Position: Q1 2024 in Review

Jupiter Asset Management sold out of Usana Health Sciences (USNA) in Q1 2024, closing a stake of 18,244 shares — an estimated $978K sold.

Jupiter Asset Management first reported a position in USNA in Q3 2020 and held it in 11 quarters. The position peaked at $3.3M in Q1 2022. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.

Jupiter Asset Management reported no remaining Usana Health Sciences position as of Q1 2024 after selling out during the quarter.
Jupiter Asset Management sold 18,244 Usana Health Sciences shares in Q1 2024, an estimated $978K.
Jupiter Asset Management first reported a position in Usana Health Sciences in Q3 2020 and held it in 11 quarters.
Jupiter Asset Management's Usana Health Sciences position peaked at $3.3M in Q1 2022.
161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.

Based on Jupiter Asset Management's 13F filing for Q1 2024, filed 10 May 2024.